Sofinnova Partners SAS - 15 Aug 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role: 10%+ Owner
Signature: Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner
Issuer symbol: N/A
Transactions as of: 15 Aug 2022
Net transactions value: +$3,999,990
Form type: 4
Filing time: 17 Aug 2022, 16:19:11 UTC
Previous filing: 13 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Purchase	$3,999,990	+133,333	+3.3%	$30.00	4,220,979	15 Aug 2022	By Sofinnova Capital IX	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sofinnova Partners SAS is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.